|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 842.55 INR | -0.19% |
|
-7.41% | -4.69% |
| 06/01 | Fortis Healthcare says tax authority confirms demand of 59.8 million rupees | RE |
| 06/01 | Crisil Affirms Ratings on Fortis Healthcare's Bank Loan Facilities; Outlook Stable | MT |
| Capitalization | 64TCr 695.76Cr 594.87Cr 552.21Cr 517.89Cr 960.8Cr 1.03TCr 6.34TCr 2.51TCr 30TCr 2.61TCr 2.56TCr 1,10000Cr | P/E ratio 2026 * |
57.2x | P/E ratio 2027 * | 43.7x |
|---|---|---|---|---|---|
| Enterprise value | 65TCr 714.58Cr 610.96Cr 567.14Cr 531.9Cr 986.79Cr 1.06TCr 6.51TCr 2.58TCr 31TCr 2.68TCr 2.62TCr 1,13000Cr | EV / Sales 2026 * |
7.11x | EV / Sales 2027 * | 5.97x |
| Free-Float |
64.76% | Yield 2026 * |
0.16% | Yield 2027 * | 0.19% |
Last Transcript: Fortis Healthcare Limited
| 1 day | -0.19% | ||
| 1 week | -7.41% | ||
| Current month | -4.69% | ||
| 1 month | -7.83% | ||
| 3 months | -23.26% | ||
| 6 months | +5.02% | ||
| Current year | -4.69% |
| 1 week | 832 |  | 915 |
| 1 month | 832 | | 950.45 |
| Current year | 832 | | 950.45 |
| 1 year | 577 | | 1,104.3 |
| 3 years | 245.5 | | 1,104.3 |
| 5 years | 156 | | 1,104.3 |
| 10 years | 107.1 | | 1,104.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | 19/03/2019 | |
| Director of Finance/CFO | - | 08/04/2019 | |
Daljit Singh
PSD | President | 73 | 01/09/2002 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 60 | 27/04/2018 | |
| Chairman | 70 | 01/10/2024 | |
| Director/Board Member | 63 | 19/03/2019 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.19% | -7.41% | +31.65% | +197.25% | 695.76Cr | |
| +0.47% | +0.83% | +18.38% | +44.07% | 1.85TCr | |
| -1.06% | -5.41% | -10.04% | -56.87% | 1.5TCr | |
| -0.24% | -6.35% | -1.57% | +57.09% | 1.07TCr | |
| +1.49% | +15.91% | -12.82% | -32.00% | 1.04TCr | |
| +0.26% | +0.17% | +27.67% | +90.94% | 1.02TCr | |
| +0.59% | -0.81% | +3.78% | +58.60% | 1TCr | |
| +1.07% | +14.11% | -22.04% | - | 846.95Cr | |
| +0.40% | +0.95% | +11.95% | -44.90% | 575.95Cr | |
| Average | +0.31% | +0.67% | +5.22% | +39.27% | 1.07TCr | |
| Weighted average by Cap. | +0.26% | +0.42% | +4.82% | +32.84% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 9.2TCr 100.49Cr 86Cr 80Cr 75Cr 138.77Cr 148.59Cr 915.31Cr 362.21Cr 4.35TCr 376.83Cr 369.12Cr 16TCr | 11TCr 118.1Cr 100.97Cr 94Cr 88Cr 163.09Cr 174.63Cr 1.08TCr 425.69Cr 5.11TCr 442.87Cr 433.81Cr 19TCr |
| Net income | 1.12TCr 12Cr 10Cr 9.71Cr 9.1Cr 17Cr 18Cr 111.41Cr 44Cr 529.49Cr 46Cr 45Cr 1.93TCr | 1.46TCr 16Cr 14Cr 13Cr 12Cr 22Cr 24Cr 144.76Cr 57Cr 688.02Cr 60Cr 58Cr 2.51TCr |
| Net Debt | 1.72TCr 19Cr 16Cr 15Cr 14Cr 26Cr 28Cr 171.42Cr 68Cr 814.7Cr 71Cr 69Cr 2.98TCr | 897.24Cr 9.8Cr 8.38Cr 7.77Cr 7.29Cr 14Cr 14Cr 89Cr 35Cr 424.05Cr 37Cr 36Cr 1.55TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/26/22 | 842.55 ₹ | -0.19% | 10,83,167 |
| 21/26/21 | 844.15 ₹ | -1.44% | 25,37,960 |
| 20/26/20 | 856.45 ₹ | -3.99% | 26,44,957 |
| 19/26/19 | 892.05 ₹ | -0.49% | 11,73,321 |
| 16/26/16 | 896.45 ₹ | -1.48% | 21,71,062 |
Delayed Quote NSE India S.E., January 22, 2026 at 12:26 pm IST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- FORTIS Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition